← Back to Search

Device

Comparison for patients of lumbar drain and shunt surgery for Normal Pressure Hydrocephalus (NPH Trial)

N/A
Waitlist Available
Led By Laura Pare, MD, FRCSC
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 min per clinic visit
Awards & highlights
No Placebo-Only Group

Summary

The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.

Eligible Conditions
  • Normal Pressure Hydrocephalus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial and follow-up visits
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial and follow-up visits for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evans Ratio
Secondary study objectives
Physical Therapy, Occupational Therapy, and Speech Therapy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Comparison for patients of lumbar drain and shunt surgeryExperimental Treatment2 Interventions
Subjective comparisons made for patients - before and after external lumbar drain, before and after shunt surgery. Device: Programmable Shunt Insertion (Codman Medtronic) Behavioral: Assessments in physical therapy, occupational therapy, and speech therapy Follow-up testing to be administered by trained physician assistant in the outpatient setting on an approximately monthly basis: 10m walk, timed up-and-go, mini-mental status exam, 9-hole grooved pegboard, motor visual perception test (MVPT), modified rankin score (MRS)

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
565 Previous Clinical Trials
1,932,934 Total Patients Enrolled
Laura Pare, MD, FRCSCPrincipal InvestigatorUC Irvine
~1 spots leftby Dec 2025